Hae Mi Byun

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Translational and clinical pharmacology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Byoung Chul Cho, Myung-Ju Ahn, Jin Hyoung Kang, Ross Andrew Soo, Thanyanan Reungwetwattana, James Chih-Hsin Yang, Irfan Cicin, Dong Wan Kim, Yi-Long Wu, Shun Lu, Ki Hyeong Lee, Yong-Kek Pang, Anastasia Zimina, Chin Heng Fong, Elena Poddubskaya, Ahmet Sezer, Soon Hin How, Pongwut Danchaivijitr, YuKyung Kim, Yeji Lim, Taewon An, Hana Lee, Hae Mi Byun, Bojan Zarić
Lazertinib Versus Gefitinib as First-line Treatment in Patients With EGFR -mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Results From LASER301. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sukyong Yoon, EunSil Oh, Min Soo Park, Seong Bok Jang, Hae Mi Byun, Hyeonsoo Park, Heeyoung Kim, Choon-Ok Kim
Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimen. Translational and clinical pharmacology 29 (3) (2021)